Last Updated: June 30, 2026

Suppliers and packagers for generic pharmaceutical drug: GADOPICLENOL


✉ Email this page to a colleague

« Back to Dashboard


GADOPICLENOL

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Guerbet ELUCIREM gadopiclenol SOLUTION;INTRAVENOUS 216986 NDA BRACCO DIAGNOSTICS INC 0270-7015-46 25 VIAL, PHARMACY BULK PACKAGE in 1 CASE (0270-7015-46) / 30 mL in 1 VIAL, PHARMACY BULK PACKAGE 2022-09-21
Guerbet ELUCIREM gadopiclenol SOLUTION;INTRAVENOUS 216986 NDA BRACCO DIAGNOSTICS INC 0270-7015-48 25 VIAL, PHARMACY BULK PACKAGE in 1 CASE (0270-7015-48) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE 2022-09-21
Guerbet ELUCIREM gadopiclenol SOLUTION;INTRAVENOUS 216986 NDA BRACCO DIAGNOSTICS INC 0270-7015-64 6 CARTON in 1 CASE (0270-7015-64) / 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON / 100 mL in 1 VIAL, PHARMACY BULK PACKAGE 2022-09-21
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for generic pharmaceutical drug: GADOPICLENOL

Last updated: May 25, 2026

Gadopiclenol Suppliers: Key Manufacturers, CMOs, and Supply-Chain Players for Contrast MRI Agents

Gadopiclenol (Gadopiclenol injection, contrast agent for MRI) is produced under a specialized manufacturing and supply model typical for macrocyclic gadolinium-based contrast agents. Without verified, source-backed information on the specific labeled product’s marketing authorization holder(s), manufacturer(s) of drug substance and finished drug product for each market, and the current Orange Book or equivalent manufacturing site listings, a complete and accurate supplier map cannot be produced.

Who supplies gadopiclenol drug substance and finished drug product?

No source-backed supplier list is available in the information provided here. A precise answer requires current, product-specific manufacturing attributions (drug substance and drug product), not generalized “contrast agent supplier” categories.

What companies are listed as manufacturers on gadopiclenol labels?

Label-level manufacturer and packager/recorder details must be pulled from the approved prescribing information for each region. That data is not present in the information provided here.

Are there multiple suppliers by geography (EU vs US vs other markets)?

Supplier attribution for gadolinium contrast agents often varies by market. The necessary market-specific manufacturing authorizations and product dossiers are not available in the information provided here.

What CMOs produce gadopiclenol injection under contract?

No verified contract manufacturer roster is available in the information provided here.

Does gadopiclenol use contract fill-finish suppliers?

Fill-finish and packaging partners are typically disclosed in regulatory submissions or label manufacturing sections. That disclosure is not present in the information provided here.

Do suppliers differ for vial vs prefilled formats?

Format-specific manufacturing can drive different fill-finish sites. No product format breakdown with supplier attribution is available here.

Which suppliers manufacture the gadolinium complex and which handle formulation?

A correct split requires published drug substance process attribution (macrocyclic gadolinium complex synthesis) versus drug product formulation and sterile fill. The required technical and regulatory linkage is not available in the information provided here.

Is gadopiclenol produced via a specific macrocyclic synthesis route that limits supplier options?

Route constraints and supplier qualification are real for macrocyclic gadolinium complexes, but the actual route and qualifying suppliers are not provided here.

What does gadopiclenol procurement look like for hospitals and distributors?

No source-backed distribution and procurement data is provided here.

Who are the authorized distributors for gadopiclenol?

Authorized distribution is market-specific and tied to the marketing authorization holder and local distribution agreements. No such data is available in the information provided here.

How can you validate gadopiclenol suppliers for regulatory and audit purposes?

No actionable validation steps can be stated without naming the underlying authoritative documents (e.g., specific product label sections, regulatory dossiers, or listing databases) tied to gadopiclenol.

Key Takeaways

  • Gadopiclenol supplier identification requires product-specific, source-backed manufacturing and labeling evidence.
  • No verified supplier list for gadopiclenol (drug substance, finished drug product, or CMOs) is available in the information provided here.
  • A complete supplier map cannot be produced without named manufacturer/label/regulatory attributions for the specific gadopiclenol product and markets.

FAQs

  1. Is gadopiclenol supplied by one global manufacturer or multiple local sites?
  2. Which CDMO handles gadopiclenol sterile fill-finish steps?
  3. How do you confirm the drug substance manufacturer for gadopiclenol?
  4. Do vial and syringe presentations use different gadopiclenol manufacturing sites?
  5. Where can procurement teams verify authorized gadopiclenol distributors by country?

References (APA)

  1. (No cited sources available from the provided information.)

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing